Study Title
CCTL019A2205B: Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy
Protocol ID
CCTL019A2205B
Condition/s
Patients who have received CAR-T cell therapy
Diagnosis Stage
Previously treated
Location
VIC
Sponsor
Novartis Pharmaceuticals
Collaborators
University of Pennsylvania
Links
Trial Status
Open
Sites
Royal Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
Child, Adult, Older Adult
International registry ID's
NCT02445222
| Study Title | CCTL019A2205B: Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy |
|---|---|
| Protocol ID | CCTL019A2205B |
| Disease (Sub Disease) | Patients who have received CAR-T cell therapy |
| Diagnosis Stage | Previously treated |
| Location | VIC |
| Sponsor | Novartis Pharmaceuticals |
| Collaborators | University of Pennsylvania |
| Links | https://clinicaltrials.gov/ct2/show/NCT02445222 |
| Trial Status | Open |
| Trial Open Date | 02/11/2015 |
| Sites | Royal Children's Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | Child, Adult, Older Adult |
| International registry ID's | NCT02445222 |